Key Details

  • Board meeting scheduled for August 13, 2026
  • Purpose: To consider, approve, and take on record the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026

Trading Window Closure

  • Trading window for dealing in the company's securities has been closed from July 1, 2026
  • Closure will remain effective until 48 hours after the public announcement of the Audited Financial Results
  • This is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015

Additional Information

  • The intimation has been uploaded on the company's website: www.caprolactam.co.in
  • The disclosure is signed by Zaver Shankarlal Bhanushali, Managing Director (DIN: 00663374)